Skip to main content

FDA Registration Assistance

Class I II III Medical Device Classification
Medical Devices · Classification
Last updated:

Class I, II & III Medical Device Classification

FDA sorts every medical device into one of three risk-based classes, and the class sets the market pathway. Class I (low risk) needs general controls, and most are 510(k)-exempt (bandages, exam gloves, tongue depressors). Class II (moderate risk) needs general controls plus special controls, and most require a 510(k) — demonstrating substantial equivalence to a legally marketed predicate (catheters, tampons, pregnancy tests, infusion pumps). Class III (high risk) needs general controls plus PMA — premarket approval with clinical evidence (pacemakers, heart valves, implants). The class is set by intended use and indications, found via FDA's product classification database (product code + regulation number); a novel low-to-moderate-risk device with no predicate can use De Novo. Every class needs establishment registration, device listing, a quality system (QMSR), MDR, and labeling — with a U.S. Agent if foreign. "Cleared" (510(k)) ≠ "approved" (PMA), and registration ≠ clearance. Classify first.

The three risk classes, how FDA decides which one your device is, the market pathways, and what every class must do.

Key Takeaways

  • Class I = general controls — low risk; most 510(k)-exempt.
  • Class II = general + special controls — moderate risk; most need a 510(k).
  • Class III = general controls + PMA — high risk; premarket approval with clinical data.
  • Intended use sets the class — via product code + regulation number.
  • De Novo — for novel low/moderate-risk devices with no predicate.
  • All classes: register, list, quality system, MDR, labeling — and "cleared" ≠ "approved."
The Framework

Class I vs Class II vs Class III

Class IClass IIClass III
RiskLowModerateHigh
ControlsGeneral controlsGeneral + special controlsGeneral controls + PMA
PathwayUsually 510(k)-exemptUsually 510(k)Usually PMA
FDA actionListed (often no submission)Cleared (substantial equivalence)Approved (safety + effectiveness)
ExamplesBandages, exam gloves, tongue depressorsCatheters, tampons, pregnancy tests, infusion pumpsPacemakers, heart valves, implants
The framework lives in 21 CFR Part 860 (and Subchapter H); each device type's specifics are in the classification regulations by specialty panel (21 CFR 862–892). A novel low/moderate-risk device with no predicate can request De Novo classification into Class I or II.
How FDA Decides

Classification Starts With Intended Use

A device's class isn't based on appearance — it's based on intended use and indications for use, plus risk, technology, patient contact, invasiveness, duration, energy source, software function, and how similar devices are regulated.

  • Define the intended use & indications — what the device does, and for which condition/population
  • Find the product code & regulation number — via FDA's Product Classification Database, matching intended use and technology
  • Confirm the class & pathway — the regulation states the class, any special controls, and whether 510(k)/De Novo/PMA/exemption applies
  • Check the specialty panel — classifications are organized into 16 medical specialty panels (21 CFR 862–892)
Claims can change the class. FDA reads intended use from the whole presentation — labels, website, listings, brochures. A disease/diagnostic/treatment claim can move a product to a higher class or a different product code. Two similar-looking products can classify differently based on use, technology, or claims — so the wrong product code is a real risk.
The Pathways

Exempt, 510(k), De Novo & PMA

  • 510(k)-exempt — most Class I (and some Class II); no premarket submission, but general controls and exemption limitations still apply
  • 510(k) (premarket notification) — most Class II; demonstrate substantial equivalence to a legally marketed predicate; results in clearance
  • De Novo — novel low/moderate-risk devices with no predicate; creates a new Class I/II category and a predicate for future 510(k)s
  • PMA (premarket approval) — Class III; valid scientific evidence (usually clinical) of safety and effectiveness; results in approval (21 CFR Part 814)
  • HDE — Humanitarian Device Exemption, for devices for rare conditions
"Cleared" ≠ "approved." A 510(k) device is cleared (substantially equivalent); only a Class III PMA device is approved. Calling a 510(k) device "FDA-approved" is inaccurate — and neither clearance nor registration is the same as approval.
Every Class

General Controls Apply to All Devices

Whatever the class, the general controls apply:

  • Establishment registration & device listing — 21 CFR Part 807; registration renews annually; U.S. Agent if foreign
  • Quality system — 21 CFR Part 820, transitioning to the QMSR (harmonized with ISO 13485; compliance date February 2, 2026); most Class I devices are exempt from the design-control provisions
  • Medical Device Reporting (MDR) — 21 CFR Part 803; report deaths, serious injuries, and malfunctions
  • Labeling — 21 CFR Part 801; manufacturer name/address, adequate directions, required warnings (plus UDI where applicable)
  • No misbranding or adulteration — the baseline prohibitions
Registration and listing are administrative — they don't mean FDA cleared or approved the device, and they don't replace a required 510(k)/De Novo/PMA. See U.S. Agent for device manufacturers.
Where Companies Slip

Common Classification Mistakes

  • "Class I means no FDA work" — exempt from 510(k) ≠ exempt from registration/listing/labeling/quality
  • "Registration replaces 510(k)" — it doesn't; clearance is separate
  • Wrong product code — chosen by appearance, not intended use
  • Copying a competitor's claims without confirming their legal pathway
  • Underestimating PMA — evidence, time, and cost for Class III
  • Calling a 510(k) device "approved"; missing the U.S. Agent (foreign)
Classify Before You Register

Get Your Device Classification Right

FDA Registration Assistance reviews your device's intended use and indications, identifies the likely product code and class, and flags the pathway (exempt, 510(k), De Novo, or PMA) and any special controls — then handles FDA establishment registration, device listing, and U.S. Agent support, and coordinates importer obligations. We work with manufacturers, foreign establishments, importers, distributors, and private-label brands.

Contact us at info@fdaregistrationassistance.com or call +1 (928) 275-8333 for a quote. An independent compliance firm serving 1,000+ companies across 135+ countries, with 15+ years of experience.

FAQ

Frequently Asked Questions — Device Classification

1. What are Class I, Class II, and Class III medical devices?

They are FDA's three risk-based device classes, defined by the level of control needed to give reasonable assurance of safety and effectiveness. Class I is generally lower risk (general controls; most are 510(k)-exempt - e.g., bandages, exam gloves, tongue depressors). Class II is moderate risk (general controls plus special controls; most require 510(k) clearance - e.g., catheters, tampons, pregnancy test kits, infusion pumps). Class III is highest risk (general controls plus premarket approval/PMA - e.g., pacemakers, heart valves, implants). The class sets the market pathway.

2. How does FDA decide a device's class?

By the device's intended use and indications for use, plus risk, technology, patient contact, invasiveness, duration of use, and how similar devices are already regulated. FDA organizes classifications by 16 medical specialty panels (21 CFR Parts 862–892); each device type has a product code and a classification regulation number that state its class, any special controls, and its exemption status. Classification should be based on the regulation and product code - not on appearance or marketing preference.

3. Is a Class I device automatically exempt from FDA requirements?

No. Most Class I devices are exempt from 510(k), but that is not the same as exempt from all requirements. General controls still apply: establishment registration and device listing (where the establishment role requires it), compliant labeling, the applicable quality system provisions, complaint handling, Medical Device Reporting, and import requirements. "Class I" and "510(k)-exempt" do not mean "no FDA obligations." Verify the specific exemption and the remaining duties.

4. Do most Class II devices require 510(k) clearance?

Yes - most Class II devices require a 510(k) premarket notification before marketing, unless a specific exemption applies. A 510(k) demonstrates the device is substantially equivalent to a legally marketed predicate device. Class II devices also carry special controls (device-specific performance standards, testing, labeling, or postmarket requirements) on top of general controls. Registration and listing are not a substitute for 510(k) clearance when clearance is required.

5. Do Class III devices require PMA?

Generally yes. Class III devices - those that support or sustain life, are implanted, or present a potential unreasonable risk - usually require premarket approval (PMA) under 21 CFR Part 814, FDA's most stringent pathway. A PMA must show reasonable assurance of safety and effectiveness with valid scientific evidence, typically including clinical data, plus manufacturing and quality detail. Class III should be identified early because the PMA pathway is far more demanding than 510(k).

6. What is the difference between general controls and special controls?

General controls apply to all devices (registration, listing, quality system/GMP, labeling, Medical Device Reporting, and prohibitions against misbranding/adulteration). Special controls are additional, device-specific requirements that distinguish Class II from Class I - things like performance standards, specific bench or clinical testing, special labeling, patient registries, or postmarket surveillance, tailored to the particular risks of that device type. Class III adds premarket approval on top of general controls.

7. What is the De Novo pathway?

De Novo (21 CFR Part 860, Subpart D) is a classification pathway for novel devices that are low-to-moderate risk but have no suitable predicate to support a 510(k). Rather than defaulting into Class III for lack of a predicate, a sponsor can request that FDA create a new Class I or Class II category (with special controls if Class II). A granted De Novo becomes a predicate that later devices of the same type can cite in a 510(k). It's common for digital health and novel technologies.

8. What does every device class have to do (all classes)?

The general controls apply across all classes: FDA establishment registration (21 CFR Part 807, annual) and device listing; a quality system (21 CFR Part 820, transitioning to the QMSR, which harmonizes with ISO 13485 - compliance date February 2, 2026; most Class I devices are exempt from the design-control provisions); Medical Device Reporting (21 CFR Part 803) for deaths, serious injuries, and malfunctions; compliant labeling (21 CFR Part 801); and prohibitions against misbranding and adulteration. Foreign establishments also need a U.S. Agent.

9. What is the difference between "cleared" and "approved"?

They are not interchangeable. "510(k)-cleared" means FDA found the device substantially equivalent to a predicate - it's a clearance, used for most Class II devices. "PMA-approved" means FDA approved the device based on evidence of safety and effectiveness - reserved for high-risk Class III devices. So a 510(k) device is cleared, not approved, and only PMA (Class III) devices are "FDA-approved." Using "approved" for a cleared device is a common and meaningful error.

10. What is a product code and how does it relate to class?

A product code is FDA's specific identifier for a device type; it links the device to its classification regulation number, class, submission type, and applicable controls. The device class is the risk category. Finding the right product code (via FDA's Product Classification Database, based on intended use) is how you confirm the class, whether 510(k)/De Novo/PMA/exemption applies, and any special controls. Selecting the wrong product code causes listing, import, and strategy problems.

11. Can two similar-looking devices have different classifications?

Yes. Classification is not based on appearance. Two similar-looking products can fall into different classes if they have different intended uses, indications, technology, patient populations, energy sources, software functions, or clinical settings. A claim or feature that raises new safety/effectiveness questions can move a product to a higher class or a different product code - which is why the intended use and claims must be pinned down before classifying.

12. Can marketing claims change a device's classification?

Yes. FDA determines intended use from the full presentation - labels, instructions, website, online listings, brochures, and advertising - not just the package. Adding a disease, diagnostic, treatment, or clinical-performance claim can move a product into a more demanding pathway (or make a non-device into a device). Review all consumer- and buyer-facing claims before launch, because claims can change the class and the required submission.

13. Does FDA registration mean my device is cleared or approved?

No. Establishment registration and device listing are administrative requirements - they put your establishment and products in FDA's system. They do not mean FDA reviewed, cleared, or approved the device, and they are not a substitute for a required 510(k), De Novo, or PMA. A company can be registered while its device is not lawfully marketed because a required premarket submission hasn't been obtained. Registration is not clearance.

14. Can software be a Class I, II, or III device?

Yes. Software can be a medical device (Software as a Medical Device) depending on its intended use and function. Software that analyzes medical data, supports diagnosis, recommends treatment, monitors patients, or controls another device may be regulated, and its class depends on risk and clinical impact - some are Class I or II, some higher. Many novel software/AI devices use the De Novo pathway. Classification review is essential for digital health products.

15. When should a company review device classification?

As early as possible - before finalizing claims, designing labeling, printing packaging, filing registration, listing the device, booking a shipment, launching an e-commerce listing, or signing a distributor agreement. Classification drives the entire pathway, so confirming the class and product code first prevents expensive rework (reprinting packaging, added testing, detained shipments, marketplace removals) that happens when a classification problem is discovered after production begins.

16. How does FDA Registration Assistance help with device classification?

We help review a device's intended use and indications, identify the likely product code and class, and flag the pathway (exempt, 510(k), De Novo, or PMA) and any special controls - then handle FDA establishment registration, device listing, and U.S. Agent support, and coordinate importer obligations. We work with manufacturers, foreign establishments, importers, distributors, private-label brands, and specification developers entering the U.S. market. We're an independent compliance firm serving 1,000+ companies across 135+ countries with 15+ years of experience. Contact info@fdaregistrationassistance.com or +1 (928) 275-8333.

HM
Reviewed By Hector Matos, Senior Regulatory Compliance Specialist  ·  15+ years FDA compliance experience  ·  Updated July 2026
Food and Drug Administration Contact Us for Assistance